What is the difference between Metformin (Biguanides) and SGLT2 Inhibitors (Class Overview)?

Metformin (Biguanides) belongs to the Biguanides class, while SGLT2 Inhibitors (Class Overview) belongs to the SGLT2 Inhibitors class. They both treat diabetes but work in different ways. Your doctor can help determine which is best for your specific situation.

Which is better: Metformin (Biguanides) or SGLT2 Inhibitors (Class Overview)?

Neither medication is universally "better." The choice depends on your individual health factors, medical history, other medications you take, and how your body responds to treatment. Your healthcare provider can recommend the most appropriate option for you.

Can I switch from Metformin (Biguanides) to SGLT2 Inhibitors (Class Overview)?

Never switch medications without consulting your healthcare provider. Switching requires careful consideration of your medical condition, potential drug interactions, and proper dosing. Your doctor can safely guide any medication changes.

Diabetes Comparison

Metformin (Biguanides) vs SGLT2 Inhibitors (Class Overview)

A detailed comparison of Metformin (Biguanides) and SGLT2 Inhibitors (Class Overview) to help you understand the differences and make informed decisions about your diabetes treatment.

Metformin (Biguanides)

Biguanides

Lowers blood sugar effectively

Digestive upset (nausea, diarrhea)

View full details

SGLT2 Inhibitors (Class Overview)

SGLT2 Inhibitors

Lowers blood sugar without insulin

Increased urination (especially when starting)

View full details

What They Have in Common

Both are used to treat: Type 2 diabetes
Both require monitoring: hba1c, creatinine
Both require prescription
Both should be taken as directed by your doctor

Key Differences

Metformin (Biguanides)

Dosing: Metformin (Biguanides): With meals to reduce digestive side effects. SGLT2 Inhibitors (Class Overview): Once daily, morning preferred.
Time to effect: Blood sugar lowering seen within days; full effect in 1-2 weeks
Form: Tablets: 500 mg, 850 mg, 1000 mg; Extended-release: 500 mg, 750 mg, 1000 mg; Liquid: 500 mg/5 mL

SGLT2 Inhibitors (Class Overview)

Dosing: Metformin (Biguanides): With meals to reduce digestive side effects. SGLT2 Inhibitors (Class Overview): Once daily, morning preferred.
Time to effect: Blood sugar: immediate; Heart/kidney benefits: months to years
Form: Tablets: 5mg, 10mg, 25mg (varies by agent); canagliflozin also available as 100mg, 300mg

Side Effects

Metformin (Biguanides) may cause: Digestive upset (nausea, diarrhea), Metallic taste, Decreased appetite. SGLT2 Inhibitors (Class Overview) may cause: Increased urination (especially when starting), Yeast infections, Urinary tract infections.

When to Choose Metformin (Biguanides)

1.You're newly diagnosed with type 2 diabetes (metformin is first-line)
2.Cost is a consideration (metformin is very affordable)
3.You want a medication with a long safety record

When to Choose SGLT2 Inhibitors (Class Overview)

1.You have heart failure or kidney disease (SGLT2s offer protective benefits)
2.You want to lose weight (SGLT2s can help with weight loss)
3.You're at risk for cardiovascular events

Important Considerations

•Both medications require a prescription and medical supervision
•Individual response varies - what works for others may not work for you
•Never switch medications without consulting your doctor
•Both medications have serious warnings - discuss with your doctor
•Regular lab monitoring may be required
•Tell your doctor about all medications and supplements you take

Talk to Your Doctor

This comparison is for educational purposes. Only your healthcare provider can determine which medication is right for you.

Browse All Medications

This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication.